All news from Anaesthesiology
Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting breast cancer in younger women with a high-risk genetic profile than an annual mammogram, according to a research team based at the University of Chicago Medicine and the University of Washington, Seattle.
Research on local anesthetic was examined from the Department of Anaesthesiology and Intensive Care Medicine, Patients who are given a local anesthetic before having a venous cannula inserted have a clearly reduced sensation of pain when larger gauge cannulas are used. Compared with intradermal lidocaine infusion, the use of vapocoolant spray has the advantage that the rate of venepuncture failures is lower.
According to new study, Patients with atopic dermatitis (AD) also known as eczema often face a tough, uphill battle for treatment. Symptoms include severe itching, scaly rashes, extreme dry skin and inflammation. Those who suffer from AD spend sleepless, itchy nights fearing they have nowhere to turn and their symptoms may never resolve. This creates therapeutic challenges for clinicians treating AD. This study was published in Annals of Allergy, Asthma and Immunology.
Researchers found an outbreak, which appeared very severe for patients and it was reported. The number of cases then surged, with 136 in the week beginning Nov. 26, the World Health Organisation reported. Zambian President Edgar Lungu has directed the military to help fight the spread of cholera, which has killed 41 people in the nation's capital and made more than 1,500 others sick since late September.
Clinical researchers at Barts Health NHS Trust and Queen Mary University of London have found that one year on from a single treatment with a gene therapy drug, participants with hemophilia A are showing normal levels of the previously missing protein, and effectively curing them.
Researchers examined in the American College of Cardiology (ACC) has released an expert consensus decision pathway document to optimize the treatment of heart failure (HF) with reduced ejection fraction. The ACC and American Heart Association have established clinical practice guidelines as the foundation for HF care. This research got published in the Journal of the American College of Cardiology.
A new study published in The Lancet has revealed that the countries outside the western world might be facing the pattern of increasing inflammatory bowel disease (IBD) rates. The findings presented at the World Congress of Gastroenterology in Orlando, Fla.
One of Africa's most lethal diseases is actually a circadian rhythm disorder caused by the acceleration of biological clocks controlling a range of vital functions besides sleep, reports Nature Communications. By understanding which clock genes are affected by the parasitic disease, scientists hope the research will eventually prove useful in developing new therapeutic alternatives to the current toxic treatments that are occasionally fatal to patients.
Highly effective treatments for hepatitis C virus (HCV) have become available in recent years, drug-resistant viral strains can still lead to treatment failure for a sizable proportion of patients. Now, in a recent study published in PNAS Plus, reported a class of chemicals that can combat resistant strains of the HCV, as well as parasites that cause malaria and toxoplasmosis.
The scientists used to rigorous study design to show cognitive benefits in the offspring of pregnant women who daily consumed close to twice the currently recommended amount of choline during their last trimester. The study was published in the FASEB Journal
Advanced Retinal Therapy-2017 specialist conference characterised by the digital developments in personalised medicine reported that digital scan of the eye provides an accurate picture of a person’s general medical condition, facilitates early diagnosis and treatment and makes for transparent patients.
New research appear in the journal Current Atherosclerosis Reports showed that Resolvin E1 molecule if applied on gum tissues prevents and treats gum disease as well as decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot.